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Abstract
Two sensitive and reproducible capillary electrophoresis and high-performance liquid chromatography-fluorescence
procedures were established for quantitative determination of L-egothioneine in plasma. After derivatization of L-
ergothioneine with 5-iodoacetamidofluorescein, the separation was carried out by HPLC on an ODS-2 C-18 sperisorb
column by using a linear gradient elution and by HPCE on an uncoated fused silica capillary, 50 mm id, and 60 cm length.
The methods were validated and found to be linear in the range of 0.3 to 10 mmol/l. The limit of quantification was
0.27 mmol/l for HPCE and 0.15 mmol/l for HPLC. The variations for intra- and inter-assay precision were around 6 RSD%, and
the mean recovery accuracy close to 100% (96.11%).
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Introduction
L-Ergothioneine (ERT; 2-mercaptohistidine trimethylbetaine) is
an unusual sulphur-containing amino acid widely distributed in
higher plants and in the organs of several animals. ERT is
exclusively synthesized in some fungi and bacteria from the
precursors cysteine, methionine, and histidine [1]. In mammals
ERT is acquired exclusively through dietary means and accumu-
lated in cells and tissues normally exposed to oxidative stress and
involved in inflammatory response [2]. The physiological functions
so far suggested for ERT span a wide range and include
antioxidant and scavenging activities [3], protection against
ischemia/reperfusion-induced injury [4], regulation of metalloen-
zymes [5], inhibition of DNA oxidation by peroxynitrite
(ONOO2) in the human neuronal hybridoma cell line [3],
catalysis of carboxylation or decarboxylation reactions [6],
neuroprotection against NMDA excitotoxicity in rats, transport
of cations or carbon dioxide [7], neuroprotection against cisplatin
toxicity in mice [8], and mediation of thyroid or anticholinergic
action [6]. ERT also chelates redox-active bivalent cations such as
copper and zinc [9,10], prevents the pro-oxidant effects of copper
[11], and shows radioprotective activity even at low concentrations
[12]. In a pathological context, unexpected high levels of ERT
have been observed in the blood of patients affected by
autoimmune disorders such as rheumatoid arthritis and Crohn’s
disease [13,14]. However, despite the efforts, the major biological
role of ERT has not been clarified yet. Analytical procedures for
evaluation of ERT contents [15–20] have been developed since its
discovery but none of these assays have proved to be suitable for a
convenient general use as they have long runtime or it is difficult to
obtain analytical equipment. Moreover, these assay methods have
been principally developed to determine higher concentration of
ERT and have proved to be not sensitive enough to measure the
low levels of endogenous ERT found in some matrices, such as,
e.g., plasma. As a result, the analysis of ERT in biological matrices
other than whole blood has been hampered by the lack of
analytical methods with adequate sensitiveness. To measure ERT
in whole blood, we have recently developed a method that exploits
the ability of HILIC technique to increase the retention and the
selectivity of polar solutes [21,22] in combination with an ultra-
performance liquid chromatography. As expected, however, this
method [23] was unable to detect ERT in human plasma. In order
to increase sensitivity and performance of the analysis, in this work
we report both a rapid high-performance liquid chromatography
and a capillary electrophoresis (HPCE) method, for the quanti-
tative assay of the small amount of plasma ERT based on a
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selective pre-column derivatization with 5-iodoacetamidofluores-
cein (5-IAF) and fluorescence detection.
Materials and Methods
Chemicals
Acetonitrile (ACN) HPLC grade was purchased from Nova
Chimica srl (Milan, Italy) while methanol (MeOH) for HPLC from
Carlo Erba Reagents (Milan, Italy). Potassium phosphate dibasic,
sodium phosphate tribasic dodecahydrate, DMSO, and 5-
iodoacetamidofluorescein (5-IAF) were obtained from Sigma
Aldrich Italia (Milan, Italy) while L-ergothioneine (ERT) from
DBA Italia srl (Milan, Italy). High-purity water was used
throughout the experiments and it was obtained by a Millipore
Milli-Q system.
Solutions
A standard solution of L-ergothioneine was prepared in
ultrapure water as a 4.36 mmol/l stock solution and stored at
220uC until use. Fresh working standard solutions were prepared
by diluting the stock solution with ultrapure water to the required
concentrations before use. 5-IAF was prepared in DMSO as a
20 mmol/l stock solution and stored at 220uC until use. Fresh
working 5-IAF solution was obtained by diluting the stock solution
to 770 mmol/l with a freshly daily 150 mmol/l sodium phosphate
tribasic dodecahydrate solution at pH 13.
Sample Treatment
To precipitate the proteins, a 100 ml-volume of ACN was added
to 100 ml of sample and mixed thoroughly by vigorous vortex-
mixing. After centrifugation at 170006g for 10 min at room
temperature, 50 ml of the 5-IAF working solution were added to
150 ml of supernatant and, after vigorous vortex-mixing, reaction
mixture was left in a light-protected area for 30 min at room
temperature. Finally, for the HPLC and HPCE analysis, samples
were diluted with water two and fifty times respectively.
Participants to Study and Sample Collection
The samples for this study were derived from our previous work
[24], by simple random sampling of the subjects belonging to the
control cohort. In particular, were randomly selected thirty-four
apparently healthy volunteers (16 males, 18 females) aged from 66
to 94. After informed, written consent was obtained, then whole
blood was collected by venipuncture in 5.4 mg K3EDTA
vacutainer tubes. Without delay, it was centrifuged at 4u and
3000 g for 10 minutes to separate plasma, which was stored for
five years at 280uC before analysis. The study was performed
according to the Declaration of Helsinki and all procedures were
approved by the ethics committee of Azienda USL nu1 - Sassari
(710/2/L 2008).
HPLC Equipment and Chromatographic Conditions
The LC system consisted of a Waters system model Alliance
2695 equipped with a Waters 474 fluorescence detector. The
separation was achieved on a 250 mm64.6 mmWaters C18 5 mm
spherisorb ODS2 column by using two eluents composed of a
mixture of 100 mmol/l potassium phosphate dibasic/ACN/
MeOH/water (40:7:3:50, v/v/v/v) (Eluent A) and of a mixture
of a mixture of 100 mmol/l potassium phosphate dibasic/ACN/
MeOH/water (40:20:3:37, v/v/v/v) (Eluent B). Both mobile
phases were filtered through a disposable 0.22-mm membrane filter
(Millipore, Milford, MA, USA) to remove any particulate matter
prior to their use. The eluents were delivered to the chromato-
graphic column applying a linear gradient elution starting with
Eluent A changing to Eluent B after 6 min and then to Eluent A
after 3 min. The elution was continued for 7 min keeping a flow-
rate of 1.2 ml min-1 for the entire duration of the running.
Separation was carried out in an air-conditioned room at about
25uC and samples were held at 10uC in the autosampler. Amount
injected was 2 ml and column eluates were detected by fluores-
cence detector at an excitation wavelength of 494 nm and
emission wavelength of 518 nm with the signal gain set at6100
scale expansion.
Figure 1. The reaction course of 5-IAF with L-ergothioneine. Iodoacetamide moiety of 5-IAF reacts specifically with -SH group of ERT to yield
the stable 5-IAF-ERT thioether which emits green fluorescence with a maximum at 518 nm when it is excited at 494 nm.
doi:10.1371/journal.pone.0070374.g001
HPLC/HPCE-Fluorescence Assay of L-Ergothioneine
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HPCE Equipment and Electrophoretic Conditions
For the electrophoretic experiments, a HPCE P/ACE MDQ
system equipped with a laser-induced fluorescence detector (LIF)
was used (Beckman-Coulter, Fullerton, CA, USA). The system was
fitted with a 30 kV power supply with a current limit of 300 mA.
The analysis was performed in an uncoated fused silica capillary,
50 mm id, and 60 cm length (50 cm to the detection window),
injecting 3.87 nl of sample (0.5 psi65 s). The separation was
carried out by using a 20 mmol/l sodium phosphate tribasic
dodecahydrate solution as the running buffer, 15uC, and 30 kV
(70 mA) at normal polarity. Derivatized samples were held at 10uC
Figure 2. The yield of thioether 5-IAF-ERT as a function of the concentration of the sodium phosphate tribasic dodecahydrate
buffer ([BUFFER]) used to prepare the working solution of 5-IAF. The peak area reached a maximum at a buffer concentration of 200 mmol/l,
but due to occasional precipitation of the buffer, in the definitive procedure its concentration was fixed in 150 mmol/l.
doi:10.1371/journal.pone.0070374.g002
Figure 3. The yield of thioether 5-IAF-ERT as a function of the reaction time. Derivatization conditions were described in the text.
doi:10.1371/journal.pone.0070374.g003
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in the autosampler and detected by LIF detector. After each run,
the capillary was equilibrated with running buffer for 1 min.
Results and Discussion
Human plasma contains 2 to 9 fold less ERT than erythrocytes
[25], therefore, an improvement of the response in the detection
system by derivatization with reagents affording chromophores or
fluorophores, is required for its analysis in such matrix. ERT, in
fact, has no intrinsic fluorophores and the analytically useful
absorption spectrum in the UV range, molar extinction coefficient
e of 1.461024 M21 cm21 at 257 nm [2], is not sufficient to allow
its detectability at low levels. The chemical structure of ERT
reveals that the molecule contains both a carboxyl and a thiol
group capable of derivatization. However, taking into account that
the reactivity of the carboxylic group is lower than that of the thiol,
that for its derivatization, usually, catalysts are needed and that in
a biological matrix carboxylic-containing compound are more
numerous than thiol, in this work we have used an idoacetamide
derivate of fluoresceine, 5-IAF, which possess a thiol-reactive
iodoacetyl group at 5-carbon position of the lower ring [26]. This
choice also arises from considerations on the tautomerism of ERT.
In aqueous solution, in fact, ERT exists as a tautomer between its
thiol and thione forms with the last predominating at physiological
pH. This peculiar attribute is accountable for the stability and
reactivity of ERT compared to other naturally occurring thiols. As
thione, in fact, ERT does not react with some sulfhydryl reagent
making it difficult its derivatization with common thiol-modifiers
such as DTNB. As reported by Carlsson et al, iodoacetamide
(IAA), another sulfhydryl-reactive alkylating reagent, is an
exception. IAA, as well pH values above 9, are able to destroy
the thione character of the ERT by inducing the proton loss from
imidazole nitrogen [15]. The use of an idoacetamide derivate such
as 5-IAF and of high pH values seemed therefore the most suitable
choice to ensure a quantitative derivatization of ERT. Figure 1
shows the course of the reaction of 5-IAF with ERT. 5-IAF was
highly reactive with the thiol group and, as already reported in our
previous works for the other physiological thiols [27,28], the
reaction proceeded at room temperature in the dark. Figure 2 and
3 display the yield of thioether conjugate (5-IAF-ERT) as a
function of the concentration of the sodium phosphate tribasic
dodecahydrate buffer used to prepare the working solution of 5-
IAF and of the reaction time. The peak area reached a maximum
at a buffer concentration of 200 mmol/l (see figure 2) and a
plateau over 20 min (see figure 3). However, by using the sodium
phosphate tribasic dodecahydrate buffer at the concentration of
the maximum reaction yield (200 mmol/l), due to an occasional
precipitation of the salt, also a poor reproducibility and random
deviations from linearity was obtained. In the definitive procedure,
therefore, the concentration of the buffer was fixed in 150 mmol/l
and the length of the reaction time in 30 min. 5-IAF concentration
was optimized in order to reach the greatest sensitivity quickly and
it was substantially the same found in our earlier works. Figure 4
shows both a chromatogram and an electropherogram of a real
and of a blank sample. Without interfering peaks, ERT peak was
clearly separated from the others in less than 6 (5.2) and 8 (7.5)
min in HPLC and HPCE procedures, respectively. Although ERT
was eluted from the chromatographic column in fairly short time,
to avoid that unreacted 5-IAF continued to elute in subsequent
runs, it was necessary to set an elution by gradient. By this way, the
total time required for a single run was 11 min and, despite the
gradient, from run to run the peak shape was reproducible without
Figure 4. Representative chromatograms of (a) a blank and (b) a real sample and electropherograms of (c) a blank and (d) a real
sample. Multiple peaks were mainly due to the unreacted 5-IAF.
doi:10.1371/journal.pone.0070374.g004
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distortions as well as retention time and peak area. The calibration
plot for ERT showed excellent linearity over a concentration
range of 0.3 to 10 mmol/l (R‘2= 0.999) both in the HPLC and
HPCE analysis. Intra- and inter-assay precision evaluated by
performing 3 replicate analyses of a 0.32, 1.81 and 3.52 mmol/l
plasma pool was around 6 RSD% both for HPLC and HPCE
analysis. The exact concentrations of these samples (0.32, 1.81 and
4.52 mmol/l) were obtained by multiple addition method and the
Figure 5. Comparison of data by (a) Sotgia curve and (b) Bland-Altman test. Sotgia regression shows the magnitude difference between
the values obtained by HPLC or HPCE from each other and around the line of best fit (average versus average) and provides, as an index of
agreement between two methods, a coefficient of determination of 0.9957. Bland–Altman plot shows the differences between the values obtained
by HPLC and HPCE method against their averages. Bland–Altman test showed that HPCE method gave, on average, values higher than those of HPLC
assays with a bias of 20.06 and limits of agreement ranging between 0.34 and 20.46.
doi:10.1371/journal.pone.0070374.g005
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values were superimposable between HPLC and HPCE method.
Recovery experiments conducted to determine the accuracy of the
method were performed by spiking 100 ml of a biological sample
with 10 ml of standard ERT solutions at three concentration levels
(10, 30 and 90 mmol/l). The mean recovery accuracy, calculated
as recovery(%) = 100x((C1-C0)/A), where C0 and C1 are deter-
mined compound concentrations before and after compound
addition, and A is the quantity of compound added, was close to
100% (96.11%). The limit of detection (LOD) and the limit of
quantification (LOQ) calculated on three calibration curves
following, respectively, the equations 3.3s/S and 10s/S, where
s is the standard deviation of the response and S the slope of the
calibration plot, were on average around 0.09 and 0.27 mmol/l for
HPCE and 0.05 and 0.15 mmol/l for HPLC. The established
procedure was applied to the determination of ERT in the
enrolled thirty-four volunteers. The average ERT level
(mean6SD) in these samples was 1.7161.60 mmol/l and
1.7761.64 mmol/l for the HPLC and HPCE analysis, respective-
ly. By using Sotgia test [29] and Bland-Altman test [30], the results
obtained by HPLC were compared with those obtained by
analyzing the same samples with HPCE. The output of this
comparison was displayed in figure 5 and it showed a good
agreement among data, ensuring the accuracy of both methods.
Conclusion
To our knowledge, this is the first work that describes a HPCE
assay for the plasma ergothioneine measurement. Derivatization
with 5-IAF was also a novelty for the ergothioneine quantification.
Both HPLC and HPCE methods were accurate and sensitive
enough to measure the small amount of ERT contained in plasma.
The pre-column derivatization with 5-IAF was reliable and,
together with an easy pre-treatment of the samples, quite fast to
allow quick analysis. On the whole, the new assay may be useful
for routine analyses, both in the clinical and in the research field,
and may help in the understanding of the physiology of this
unusual amino acid.
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